Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Breast Shield Designs on Dynamics of Breast Pumping (BSD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02719548
Recruitment Status : Completed
First Posted : March 25, 2016
Last Update Posted : February 10, 2020
Sponsor:
Information provided by (Responsible Party):
Medela AG

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
A prospective, randomized, 2-phase/crossover, single center premarket feasibility study. In phase I the comfort will be assessed, the occurence and types of adverse events will be recorded and the assessment how and if the different breast shield designs interact with the lacting breast during pumping. Phase II takes place at home; assessment of adverse events will be recorded and the assessment how the subjects perceives the comfort of the soft edge breast shield during mid term use at home.

Condition or disease Intervention/treatment Phase
Lactation Device: Soft edge oval - Hard oval - Modified PF breast shield Device: Modified PF breast shield - Soft edge oval - Hard oval Device: Hard oval - Soft edge oval - Modified PF breast shield Not Applicable

Detailed Description:

This is a prospective, randomized, 2 phase/crossover, single center premarket feasibility study enrolling a total of 15 subjects. Follow up visit will be after 14 days.

The study will be divided in two phases.

The objectives of phase 1 are:

  • assessment of Comfort (subjective)
  • occurrence and types of adverse events
  • to assess if and how the different designs (shapes and soft edge) of the three provided breast shields interacts with the lactating breast during pumping, with regards to:
  • The influence of nipple size, diameter and length (measured before pumping)
  • Maximum comfortable vacuum selected by participant (mmHg)
  • Actual vacuum generated in the tunnel of the breast shields in relation to the vacuum level indicator of the breast pump (mmHg)
  • Characteristics of nipple movement in the tunnel during pumping
  • Amount of tissue entering the tunnel at maximum applied vacuum (mm)
  • Amount of tissue entering the tunnel at minimum applied vacuum (mm)
  • Space between breast and shield (mm)

The objectives of phase 2 are

  • to assess how the participants perceive the comfort of the soft-edge breast shield during mid term use at home
  • to assess which adverse events occur

Study procedures - Phase 1 The participant will be invited for a pumping session (3 times 2 minutes of expression) at Medela Headquarters. The CE-marked Freestyle breast pump and its pumpset will be used in the both phases of the study.The participants will be asked to pump 3 times with each of the 3 breast shields in a randomized order. Each pump session (defined as pump start till pump stop) will be short (2 minutes of pumping after milk ejection has occurred), and all three short pumping session will be done on the left side only. All pump session will start with the stimulation mode and change to expression mode as soon as milk flows.

Study procedures - Phase 2 Once the debriefing is finished the participants will be instructed about the Phase 2 (home use) part of the study and its equipment to be used. Study subjects that do not have a Freestyle system in use, a system will be provided. All subjects will be provided with the applicable breast shield types and introduced as well as the new shields will be handed over.

  • the soft-edge breast shield (non CE-marked) and
  • the modified PersonalFit Breast Shield (non CE-marked) This part will start for each participant the day after the phase 1assessment at Medela Headquarters.

Day 1-7 (Evaluation of pumping experience with the modified PersonalFit breast shield) Day 7 (Comfort evaluation of the modified PersonalFit breast shield) Day 8-14 (Evaluation of pumping experience with the soft-edge breast shield) Day 14 (Comfort evaluation of the soft-edge breast shield)

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Impact of Breast Shield Designs on Dynamics of Breast Pumping
Study Start Date : February 2016
Actual Primary Completion Date : April 2016
Actual Study Completion Date : April 2016
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Breastshield treatment group A

Participants will be treated with the following three breast shields:

Soft edge oval - Hard oval - Modified PF breast shield Treatment order is described in the corresponding Intervention. Participant will use each breastshield for 2 min after milk ejection.

 Device: Soft edge oval - Hard oval - Modified PF breast shield

Treatment order:

  1. soft-edge oval breast shield
  2. Hard oval breast shield
  3. modified PersonalFit breast shield
Other Name: Group A
Experimental: Breastshield treatment group B

Participants will be treated with the following three breast shields:

Modified PF breast shield - Soft edge oval - Hard oval Treatment order is described in the corresponding Intervention. Participant will use each breastshield for 2 min after milk ejection.

 Device: Modified PF breast shield - Soft edge oval - Hard oval
  1. modified PersonalFit breast shield
  2. soft-edge oval breast shield
  3. Hard oval breast shield
Other Name: Group B
Experimental: Breastshield treatment group C

Participants will be treated with the following three breast shields:

Hard oval - Soft edge oval - Modified PF breast shield Treatment order is described in the corresponding Intervention. Participant will use each breastshield for 2 min after milk ejection.

 Device: Hard oval - Soft edge oval - Modified PF breast shield
  1. Hard oval breast shield
  2. soft-edge oval breast shield
  3. modified PersonalFit breast shield
Other Name: Group C


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Endpoint Phase 1_Optical analysis via photo: pumping sessions of the nipple and breast will be video recorded from the lateral side view; study set up will be filmed and the audio data taken to document all the information [ Time Frame: End of phase I (is defined from the date when moms are coming for Phase I, which takes up to 2 weeks. But the visit itself per mom takes approx. 2hours) ]
    During all three short pumping sessions the nipple and breast will be video recorded from the lateral side view. The study set up will be filmed and the audio data taken to document all the information e.g. nipple movement in the tunnel.

  2. Endpoint Phase 1_Retrospective analysis via Video: by changing the shape of the breast shield the form of the breast shield will better suit and conform to the breast shape [ Time Frame: End of phase I (is defined from the date when moms are coming for Phase I, which takes up to 2 weeks. But the visit itself per mom takes approx. 2hours) ]

    It is theorized that by changing the shape of the breast shield the form of the breast shield will better suit and conform to the breast shape, improving comfort, reducing any point compression against the skin surface, and supporting freedom of movement of the nipple in the tunnel.

    During all three short pumping sessions the nipple and breast will be video recorded from the lateral side view. The study set up will be filmed and the audio data taken to document all the information e.g. nipple movement in the tunnel.

    Retrospective analysis will be undertaken of the recorded videos. The videos will be analyzed using software for a Desktop Ruler. Characteristics of nipple movement in the tunnel during pumping/Amount of tissue entering the tunnel at max.applied vacuum(mm)/Amount of tissue entering the tunnel at min.applied vacuum(mm)/Space between breast and shield(mm)


  3. Endpoint Phase 1_ Questionnaire: After pumping with all 3 breast shields participants will be asked questions about comfort perception, handling experience and the sensation per shield. [ Time Frame: End of phase I (is defined from the date when moms are coming for Phase I, which takes up to 2 weeks. But the visit itself per mom takes approx. 2hours) ]
    After pumping with all 3 breast shields participants will be asked questions about comfort perception, handling experience and the sensation per shield.


Secondary Outcome Measures :
  1. Endpoint Phase 2_Pump log and questionnaires: will be asked to document each breast milk expression in the pump log.A questionnaire needs to be completed by the end of each week for the used breast shield [ Time Frame: End of phase II (Phase II takes place for 2 weeks at moms home; the end is defined as 4 weeks after end of phase I) ]

    Participants will be asked to document each breast milk expression in the pump log. The final entries can be compared for both shields, e.g. comparison of max.vacuum comfort (mmHg); milk outcome in mm.

    A questionnaire needs to be completed by the end of each week for the used breast shield as well.


  2. Endpoint Phase 2_Collection of AEs, if any: To assess which adverse events occurred during the home-test by completing the AE form [ Time Frame: End of phase II (Phase II takes place for 2 weeks at moms home; the end is defined as 4 weeks after end of phase I) ]
    - To assess which adverse events occurred during the home-test by completing the AE form


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Female over 18 years
  • The participant agrees to pump or feed the last time a minimum of 3 hours before the start of the pumping sessions (phase 1)
  • The participant agrees to photograph and video record the breast and upper body (no face) as well as to take audio data.
  • Participant agrees to the presence of up to 3 men in the room during the pumping session
  • The participant has been pumping at least 7 times in the week prior to study participation, no matter which electric pumps.
  • The participant has been consistently pumping 10 ml of milk or more per breast, per pumping session prior to study participation.
  • The participant currently use a breast shield size of 24 mm
  • The participant has agreed to pump at least 7 times a week over the next three weeks

Exclusion Criteria:

- none

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02719548


Locations
Layout table for location information
Switzerland
Medela AG
Baar, Zug, Switzerland, 6340
Sponsors and Collaborators
Medela AG
Investigators
Layout table for investigator information
Principal Investigator: Danielle Prime, PhD Medela AG, Lättichstrasse 4b, 6340 Baar
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Medela AG
ClinicalTrials.gov Identifier: NCT02719548    
Other Study ID Numbers: MBF1505
First Posted: March 25, 2016    Key Record Dates
Last Update Posted: February 10, 2020
Last Verified: April 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No